Nuo Therapeutics, Inc. announced that it has entered into a securities purchase agreement for private placement of 500,000 common shares at a price of $1 per share for proceeds of $500,000 on August 24, 2022. The transaction will include participation from Pacific Medical, Inc. The transaction will also issue two warrants. The first warrant entitles to purchase up to 250,000 shares of common stock at a price of $1.00 per share upon company attaining certain performance goals set forth in the first warrant based upon exceeding sales quota revenue, as agreed between the company for calendar years 2023 and/or 2024.

The second warrant entitles company to purchase up to 200,000 shares of common stock at a price of $1.50 per share upon company attaining certain performance goals set forth in the second warrant based upon exceeding sales quota revenue, as agreed between the Company for calendar years 2024 and/or 2025. The first warrant will expire December 31, 2027 and the second warrant will expire December 31, 2028. The closing of the sale of 500,000 shares of common stock and the issuance of the first warrant and second warrant is anticipated to occur on September 12, 2022.